Dr. Reddy's Laboratories (DRREDDY) — Announcement

📢 Key Event
CEO Deepak Sapra resigns effective November 12, 2026

💡 Investor Takeaway
This leadership change may affect near-term operational continuity and strategic execution in the API and services segment.

Dr. Reddy's Laboratories announced the resignation of CEO Deepak Sapra from the Senior Management Personnel effective November 12, 2026, to pursue external opportunities, as disclosed under SEBI Listing Regulations Regulation 30. The filing includes his resignation letter and regulatory annexure confirming cessation of employment.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How will the API and services segment be restructured after Sapra's exit?" "What is the timeline for appointing a permanent CEO replacement?" "How does this resignation impact Dr. Reddy's API revenue guidance for FY27?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 13 August 2026

GEEKAYWIRE Geekay Wires Limited Corporate Action AWFIS Awfis Space Solutions Limited Financial Results AXISCADES AXISCADES Technologies Limited Financial Results GOKUL Gokul Refoils and Solvent Limited Financial Results MAHABANK Bank of Maharashtra Announcement PRAJIND Praj Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.